June 1, 2007 โ New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
June 1, 2007 โ Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.
June 1, 2007 โZOLL Medical Corporation, a manufacturer of resuscitation devices and related software solutions, was ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 31 -- Cardiac Science Corp. announced today it has entered into a two-year marketing partnership with the City of ...
May 31, 2007 โ MediNotes Corporation, a leading provider of best-of-breed electronic medical record solutions for small ...
May 31, 2007 - The American Heart Association is launching a community-based program to reduce the toll of the deadliest kind of heart attack: an ST-elevation myocardial infarction (STEMI). The total blockage of a coronary artery is fatal unless treated quickly โ within 30 minutes for clot-dissolving drug treatment, and within 90 minutes for angioplasty.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 30, 2007 -- The Channel Group, LLC announced today that it has formed Lesanne Life Sciences, LLC, a medical ...
May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...
May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.
May 30, 2007 -- The Canadian Press reports this week that people in the greatest need of cardiac medications and interventions are less likely than moderately ill patients to get the full range of heart drugs and procedures, and it may be because they fail the "eyeball" test.
May 30, 2007 โ Cardiovascular Associates, Kingsport, TN, has announced the successful implant of a new investigational ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 29, 2007 โ Frost & Sullivan is launching a new end user study on the state of adoption for atrial fibrillation ...
May 29, 2007 โ Stentys says the results of preclinical testing of its bifurcated stent were reported at last week's ...
May 29, 2007 โ The Centers for Medicare & Medicaid Services (CMS) announced on May 25 a decision to provide coverage for Doppler monitoring of cardiac output in certain settings, removing the past noncoverage of this diagnostic test in these settings and adopting an evidence-based approach to healthcare.